OVARIAN CANCER

Fox Chase Cancer Center
With a U.S. News & World Report ranking of 11th in the country for cancer, the 100-bed center treats nothing but cancer and prides itself on offering patients technology-driven treatment delivered by quality physicians in their chosen sub-specialties. Its investigators have won some of the leading awards in medicine, including the Nobel and Lasker prizes. Fox Chase is a leader in risk-assessment programs for melanoma, GI and prostate cancers, and for women with family histories of breast and ovarian cancer (333 Cottman Avenue, 888-FOX CHASE).

Abramson Cancer Center
UPHS’s big-umbrella, with its number 29 slot in U.S. News, was recently recognized for its excellence in gynecologic services. Presently, using molecular analysis, the gynecological cancer research team is exploring the immune biology and immune therapy of ovarian cancer in an attempt to explain the immune dysfunction mechanisms of the disease. The team is also investigating the engineering of vaccines for ovarian cancer. Moreover, at any given time, 200 clinical trials are available to patients at the center, supported by a whopping $200 million in federal grants (3400 Spruce Street, 800-789-PENN).

Kimmel Cancer Center at Jefferson Hospital
The 150 physicians and scientists at the Kimmel Cancer Center are discovering and developing novel approaches to cancer treatment while trying to better understand the way the disease behaves. Toward this end, they conduct more than 100 clinical trials a year and manage 20 institutions in the area in the cancer-care business. They bridge mainstream medicine with alternative and complementary therapies through the hospital’s integrative medicine program and the busy radiation oncology center offers all the latest modalities. Kimmel’s Breast Care Center offers a hereditary breast and ovarian cancer program/genetic counseling that will help to determine the degree of your risk and whether you should proceed to genetic testing (233 South 10th Street, 800-JEFF-NOW).